(Q35006190)

5 August 2017

1 reference

title

The status of HPV16-specific T-cell reactivity in health and disease as a guide to HPV vaccine development (English)

1 reference

5 August 2017

1 reference

Annemieke de Jong

2

0 references

Cornelis J. M. Melief

series ordinal

5

object named as

Cornelis J M Melief

1 reference

5 August 2017

Sjoerd H van der Burg

series ordinal

1

object named as

Sjoerd H van der Burg

1 reference

5 August 2017

Marij J P Welters

3

1 reference

5 August 2017

Rienk Offringa

series ordinal

4

1 reference

5 August 2017

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

89

1 reference

5 August 2017

issue

2

1 reference

5 August 2017

page(s)

275-284

1 reference

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Stability over time of serum antibody levels to human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Cytokine Dysregulation in Invasive Cervical Carcinoma and Other Human Neoplasias: Time to Consider the TH1/TH2 Paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Quantitation of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

The serological response to papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Human papillomavirus infection is transient in young women: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Human anergic CD4+ T cells can act as suppressor cells by affecting autologous dendritic cell conditioning and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors im

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Natural history of cervicovaginal papillomavirus infection in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Multistep navigation of Langerhans/dendritic cells in and out of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

The roles of keratinocyte-derived cytokines in the epidermis and their possible responses to UVA-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Immunity to oncogenic human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Epidemiology of Genital Human Papillomavirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Detection of human papillomavirus using the polymerase chain reaction and typing for HPV16 and 18 in the cervical smears of Greek women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Interplay between human papillomaviruses and dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Tumor regression is associated with a specific immune response to the E2 protein of cottontail rabbit papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Risk of invasive cervical cancer among women with, or at risk for, HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Anergic T cells inhibit the antigen-presenting function of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900196-X

7 January 2021

10.1016/S0168-1702(02)00196-X

Identifiers

DOI

1 reference

5 August 2017

1 reference